Exenatide
6 research papers indexed
Holman 2017 — EXSCEL Exenatide Cardiovascular Outcomes
2900
New England Journal of Medicine
·2017RCTHumanType 2 diabetesSourceRCT
Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study
0
European Journal of Endocrinology
·2025Clinical TrialHumanEndogenous hyperinsulinemic hypoglycemia diagnosis
Impact of changes in conventional risk factors induced by once-weekly GLP-1 receptor agonist exenatide on cardiovascular outcomes
0
Cardiovascular Diabetology
·2025Clinical TrialHumanCardiovascular outcomes in T2D
Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy
0
Annals of Neurology
·2025Clinical TrialHumanMultiple System Atrophy (MSA)
Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder
0
Alcohol, Clinical & Experimental Research
·2025Clinical TrialHumanAlcohol use disorder
Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes
0
Diabetes Care
·2025Clinical TrialHumanType 2 diabetes